Case number 2020-2136
Cephalon, Inc. v. Slayback Pharma Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 2, 2021 | 13 | ORDER granting motion [789745-2] to dismiss Fresenius Kabi USA, LLC in appeal no. 20-2134 and to dismiss appeal no. 20-2316 pursuant to FRAP 42(b). The revised official caption is reflected in the order; issuing mandate in 20-2136. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [789971] [20-2134, 20-2136] [MVH] [Entered: 08/02/2021 03:01 PM] (3) |
| Aug 24, 2020 | 11 | ORDER consolidating appeals 20-2134, 20-2136, and 20-2137. Appellants' opening briefs are due no later than October 5, 2020. Service as of this date by the Clerk of Court. [716929] [20-2134, 20-2136, 20-2137] [KMH] [Entered: 08/24/2020 12:44 PM] (2) |
| Aug 24, 2020 | 12 | Note to File: The following cases are consolidated: 20-2134 Lead with 20-2136 and 20-2137 Consolidated Member Cases. The parties must file all documents in the lead appeal only. [716966] [20-2134, 20-2136, 20-2137] [KMH] [Entered: 08/24/2020 01:37 PM] (0) |
| Aug 20, 2020 | 2 | Entry of appearance for David I. Berl; Adam D. Harber; Shaun P. Mahaffy; Ben Picozzi; Matthew W. Lachman as counsel for Appellees Cephalon, Inc. and Teva Pharmaceuticals International GmbH. Service: 08/20/2020 by email. [716150] [20-2136] [Ben Picozzi] [Entered: 08/20/2020 12:47 PM] (2) |
| Aug 20, 2020 | 3 | Certificate of Interest for Appellees Cephalon, Inc. and Teva Pharmaceuticals International GmbH. Service: 08/20/2020 by email. [716152] [20-2136] [Ben Picozzi] [Entered: 08/20/2020 12:48 PM] (3) |
| Aug 20, 2020 | 4 | Docketing Statement for the Appellees Cephalon, Inc. and Teva Pharmaceuticals International GmbH. Service: 08/20/2020 by email. [716153] [20-2136] [Ben Picozzi] [Entered: 08/20/2020 12:49 PM] (2) |
| Aug 20, 2020 | 5 | Entry of appearance for Daniel G. Brown; Marc N. Zubick; Kenneth G. Schuler; Gabriel K. Bell as counsel for Appellee Eagle Pharmaceuticals, Inc.. Service: 08/20/2020 by email. [716235] [20-2136] [Daniel Brown] [Entered: 08/20/2020 03:00 PM] (2) |
| Aug 20, 2020 | 6 | Certificate of Interest for Appellee Eagle Pharmaceuticals, Inc.. Service: 08/20/2020 by email. [716238] [20-2136] [Daniel Brown] [Entered: 08/20/2020 03:02 PM] (3) |
| Aug 20, 2020 | 7 | Docketing Statement for the Appellee Eagle Pharmaceuticals, Inc.. Service: 08/20/2020 by email. [716239] [20-2136] [Daniel Brown] [Entered: 08/20/2020 03:04 PM] (2) |
| Aug 20, 2020 | 8 | Entry of appearance for Imron T. Aly; Kevin M. Nelson as counsel for Appellant Fresenius Kabi USA, LLC. Service: 08/20/2020 by email. [716307] [20-2136] [Imron Aly] [Entered: 08/20/2020 04:14 PM] (1) |
| Aug 20, 2020 | 9 | Certificate of Interest for Appellant Fresenius Kabi USA, LLC. Service: 08/20/2020 by email. [716310] [20-2136] [Imron Aly] [Entered: 08/20/2020 04:18 PM] (3) |
| Aug 20, 2020 | 10 | Docketing Statement for the Appellant Fresenius Kabi USA, LLC. Service: 08/20/2020 by email. [716312] [20-2136] [Imron Aly] [Entered: 08/20/2020 04:20 PM] (2) |
| Aug 6, 2020 | 1 | Appeal docketed. Received: 08/05/2020. [713034]Entry of Appearance is due on 08/20/2020. Certificate of Interest is due on 08/20/2020. Docketing Statement is due on 08/20/2020. Appellant's brief is due on 10/05/2020. [KMH] [Entered: 08/06/2020 01:06 PM] (143) |
